← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2009Last known activity
Jan 1, 2026
Timeline
1900s
- Jan 1, 1901
Butantan Institute— Founded
Drugs by trial phase (20 distinct, 26 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT07087912CollaboratorPhase 3Jan 1, 2026
- NCT06891950OfficialPhase 3Nov 30, 2025
- NCT06891950Lead sponsorPhase 3Nov 30, 2025
- NCT06842173Lead sponsorPhase 1/Phase 2Sep 1, 2025
- NCT06973772Lead sponsorPhase 3Aug 31, 2025
- NCT05779020Lead sponsorPhase 3Apr 25, 2023
- NCT05710224Lead sponsorPhase 2Feb 15, 2023
- NCT05354024Lead sponsorPhase 2/Phase 3Aug 31, 2022
- NCT05225285CollaboratorPhase 3Jan 21, 2022
- NCT04993209Study directorPhase 1/Phase 2Jul 9, 2021
- NCT04993209Lead sponsorPhase 1/Phase 2Jul 9, 2021
- NCT04834089Lead sponsorPhase 1/Phase 2May 31, 2021
- NCT04834089Study directorPhase 1/Phase 2May 31, 2021
- NCT04650399Lead sponsorPhase 3Apr 1, 2021
- NCT04650399Study directorPhase 3Apr 1, 2021
Details
- Founded
- Butantã, BR Jan 1, 1901
- Last known activity
- Jan 1, 2026